Development and Validation of New Analytical Methods for Assay of Bioactive Molecules in Various Samples: A Comparative Perspective on Different Regulatory Authorities

The process of demonstrating that analytical procedures are appropriate for their intended use and that they support the identity, quality, purity, and potency of the drug substances and drug products is known as "establishing a documented proof, which provides a high degree of assurance that a specific process will consistently produce a desired result at its prearranged specifications and quality characteristics," according to ICH Q2 (R1). When a novel method is created or when established methods are applied in several labs and by different analysts, method validation is necessary. Accuracy, precision, specificity, linearity, range, ruggedness, robustness, detection of limit, and quantitation limit are among the analytical parameters that can be verified, according to USP. Accuracy, precision, specificity, detection of limit, quantitation limit, linearity, range, system adaptability, and robustness are among the analytical parameters that can be verified, according to ICH. Accuracy, precision, specificity/selectivity, detection of limit, quantitation limit, linearity, range, system suitability, repeatability, sample solution stability, and robustness are among the analytical parameters that can be verified, according to the FDA. European rules state that the following analytical parameters can be verified: linearity, range, accuracy, precision, specificity, detection of limit, and quantitation limit. This review explains about a thorough comparison of regulatory bodies and their standards/procedures for the validation of analytical methods in pharmaceuticals and related industries. The FDA (USA), EMA (Europe), ICH, WHO, and USP are the main international organizations that establish criteria for the validation of analytical methods; hence they are the focus of the comparison.

Types of analytical procedures to be validated

The following types analytical procedures to be validated.[3]

A)  Identification tests

To confirm the identity of an analyte in a sample, identification tests are employed. This is often accomplished by comparing a sample's characteristics (such as its spectrum, chromatographic behavior, chemical reactivity, etc.) to those of a reference standard.

B) Quantitative and limit testing for controlling impurities

One way to test for impurities in a sample is to use a quantitative test to restrict the impurity. A quantitative test requires different validation settings than a limit test.

C) Measurements of the active ingredient in drug substance or drug product samples

This kind uses assay methods to quantify the analyte in a particular sample. The assay is a quantitative assessment of the drug substance's primary component or components.

2. METHOD VALIDATION'S GOALS AND BENEFITS

Objectives

1. To get accurate, dependable, and consistent data;
2. To show that it is appropriate for the purpose for which it was designed.
3. To act as a basis for recorded production and process control protocols meant to ensure pharmaceutical products' identity, potency, quality, and purity.
4. To preserve the effectiveness, safety, and quality of the final product; e. To oversee each step of the production process;
5. To produce the best analytical results

Advantages

• • It boosts confidence for both developers and users.
  • Produces high-quality items.
  • Improve product efficiency, reduce rejects, and extend equipment life to Lower costs.
  • Optimizes processes or methods.
  • Assists with process optimization, technology transfer, product validation, and greater staff knowledge.
  • Eliminating testing repetitions improves time management.

CORE VALIDATION PARAMETERS:

Understanding the qualities or parameters involved in the validation process is crucial. The different performance metrics, which are categorized as follows

• Accuracy
• Precision

• Repeatability
• Intermediate precision
• Reproducibility

• Specificity/Selectivity
• Limit of Detection (LOD)
• Limit of Quantitation (LOQ)
• Linearity
• Range
• Robustness
• Ruggedness
• System suitability testing.

a) Accuracy

Closeness of test results obtained by the method to true value" is one way to describe the accuracy of an analytical method. For example, assess the analytical method's accuracy. The assay of a known quantity of analyte in the linearity range is used to express it as a percentage of recovery.

Determination methods

Application of analytical method to an analyte of known concentration

Applying the analytical method to an analyte of known purity (such as a reference standard) and comparing the method's results with those from a different, previously validated procedure are two ways to assess its accuracy.

The spiked-placebo recovery technique

This method involves adding a known quantity of pure active substances to a formulation blank, which is a sample that contains all other ingredients but the active. The resulting mixture is then assayed, and the results are compared to expected results.

The conventional method of adding

This method involves assaying a given sample and then adding a known quantity of an active ingredient to the tested sample. This sample is then assayed once more. The disparity between the two assays' results is contrasted with the anticipated outcomes.

Recommended Data

According to the ICH document, a minimum of nine determinations per three concentration levels should be used to measure accuracy.

Acceptance criteria

The mean value should be within 15% of the supposed value except at LOQ, where it should not deviate by more than 20%. The deviation of the mean from the nominal value serves as the measure of accuracy.

b) Precision

"Closeness of agreement between a series of measurements obtained from multiple sampling of the same standardized sample under the prescribed conditions" is one way to characterize the precision of an analytical procedure. should be examined with true, homogenous samples. stated as SD/RSD

%RSD= Standard deviation Mean ×100

Repeatability

It conveys precision over a brief period of time under the same operating conditions. i.e., the analyst uses the same tools and techniques to analyze replicas.

Intermediate precision

It expresses the precision with in laboratories variations’ different days, different analyst, and different equipment’s etc. It is not necessary to study effects individually.

Reproducibility precision

It conveys the accuracy between laboratories (two-way investigations, typically applied to method standardization) for the inclusion of processes in pharmacopoeias. For example. An examination of precision is part of the validation process for assay and quantitative impurity determination procedures.

Recommended Data

For any kind of precision study, the standard deviation, relative standard deviation, and confidence interval should be provided.

Acceptance criteria

The precision determine date concentration level should not exceed 15% of the coefficient of variation (CV) except for the LLOQ, where it should not exceed 20% of the CV.

c) Specificity

According to ICH, an assay's specificity is its capacity to measure the analyte precisely and precisely in the presence of additional elements that might be anticipated to be present in the sample medium. In general, the phrase "specific" describes a technique that yields a response for just one analyte.

In particular, the ICH paper is divided into three areas.

Tests for identification

to confirm an analyte's identity.

Tests for purity

to guarantee that every analytical method carried out permits an accurate declaration of an analyte's impurity content, such as heavy metals, related compounds, etc.

Assay

to deliver a precise outcome that enables an accurate assessment of an analyte's strength or content in a sample?

d) Selectivity

selectivity of the technique to identify the analyte in the presence of elements that could be anticipated to be present in the sample matrix. It is, in essence, the capacity of a separative approach to resolve various compounds. It is a measurement of two peaks' relative method locations. It is a technique that offers answers for several chemical entities that might or might not be isolated from one another. The test results obtained on the analyte with and without the inclusion of potentially interfering material are compared to ascertain it.

e) Limit of detection

The lowest concentration of an analyte in a sample that can be identified—though not necessarily quantified—under specified experimental conditions is known as the analytical procedure's limit of detection. In essence, it shows whether the sample is over or below a particular threshold. The type of instrument as well as the analysis method will determine the LOD.

The basis for measurement is

• Visual assessment.
• The ratio of signal to noise.
• The response's standard deviation and slope

Ratio of signal to noise

This method is limited to analytical procedures that exhibit baseline noise. It determines the lowest concentration at which the analyte may be identified by comparing measured signals from samples with known low analyte concentrations with those of blank samples. Generally, a signal-to-noise ratio of 2:1 or 3:1 is acceptable.

LOD is 3.3σ/s.

where s is the calibration curve's slope and σ is the intercept's standard deviation.

f) Quantitation limit

The LOQ, which varies depending on the type of method used and the sample's characteristics, is the lowest amount of analyte in a sample that may be quantitatively determined that may be quantified with an acceptable level of accuracy and precision under the state working parameters of the method. It is typically employed to identify contaminants or degradation products.

Visual inspection and signal to noise ratio are the foundations of measurement. The slope and the response's standard deviation.

Visual assessment

Analyzing samples with known analyte concentrations and determining the lowest level at which the analyte can be identified yields the LOQ. Both instrumental and non-instrumental procedures can make use of it.

Ratio of signal to noise

This method is limited to analytical procedures that exhibit baseline noise. It determines the lowest concentration at which the analyte may be identified by comparing measured signals from samples with known low analyte concentrations with those of blank samples. It is generally agreed that the signal to noise ratio is 10:1. LOQ is stated as

LOQ= 10σ/s

Where σ is the standard deviation of the intercept and s is the slope of the calibration curve

g) linearity

The method's ability to produce test findings that are exactly proportionate to the analyte concentration within a specified range is known as linearity. Over the course of the analytical process, a linear relationship should be assessed. By diluting a standard stock solution, it can be directly determined on the drug ingredient. Plotting a graph of concentration (on the x-axis) vs mean response (only on the Y-axis) should be used to visually assess linearity. Determine the correlation coefficient, Y-intercept, and regression equation. The degree of linearity may be estimated mathematically using data from the regression line itself. It is advised to use at least five concentrations to determine linearity

h) Range

The period between the highest and lowest analyte concentration in the sample for which it has been shown that the analytical technique has an appropriate degree of precision, accuracy, and linearity is known as the range of analytical procedure. often obtained from linearity studies, and the precise range depends on how the process is intended to be used.

The minimum defined ranges listed below must to be taken into account:

• Drug material or finished product assay: 80–120% of the test concentration.
• 70 to 130% of the test concentration is the content homogeneity.
• Dissolution testing: within the designated range +/-20%;

I) Robustness

In order to give an idea of the method's variability in typical laboratory conditions, it measures the analytical method's ability to stay unaffected by minor but intentional changes in process. The stability of analytical solutions and extraction time are two examples of common differences.

Examples of common deviations in liquid chromatography include:

• The impact of pH changes in a mobile phase;
• The impact of composition changes in a mobile phase;
• An alternative column
• Temperature;
• Flow rate.

j) Ruggedness

Degree of repeatability of test results achieved by examining the same material under range of regular test settings such as various. i.e., the approach is unaffected by environmental factors. The method's ruggedness can be directly measured by comparing the reproducibility of test findings to the assay's precision. This includes analysts, instruments, days, reagents, columns, and TLC plates.

Comparison of Analytical Method Validation Guidelines

1. 1. FDA: provides comprehensive guidelines for analytical and bio analytical methods. Verification. Accepts alternative ways if scientifically supported. Promotes the life cycle approach.
   2. EMA: More focused on bio analytical techniques; less thorough for general analytical techniques.
   3. ICH: The most well recognized and standardized framework. Updated rules Q2 (R2) and Q14 present risk-based and contemporary lifecycle methodologies.
   4. WHO: Harmonized with ICH, but with a focus on accessibility and public health, this organization offers a globally relevant strategy for nations with limited resources
   5. With a heavy emphasis on system appropriateness and performance-based approaches, the USP focuses more on compendial procedures.

Authority and Validation Philosophy

FDA: Validation Philosophy emphasizes reproducibility and scientific validity. promotes a lifecycle approach, but "point-in-time" validation has historically been the main focus.

EMA: strong regulatory emphasis on bioanalytical techniques; very prescriptive with quality control (QC) standards and statistical validation.

ICH: encourages consistent, risk-based, and empirically supported validation. Lifecycle-based validation is the focus of recent revisions (Q14, Q2(R2)).

WHO: focuses on practicality and viability for environments with limited resources while adhering to ICH. contains instructions for method transfer and revalidation.

USP: emphasizes technique performance and system adaptability while concentrating on broad chapters and compendial norms. Lifecycle principles introduced in <1220>.

Type of Analytical Procedures Covered

Types of Authority Methods

FDA: Assay, identification, dissolution, contaminants, stability-indicating techniques, and bioanalytical techniques (PK/PD investigations).

EMA: The majority of drug development techniques are bioanalytical (e.g., plasma concentrations), with sporadic chemical techniques.

ICH: both biological and chemical compounds. Validation is covered in Q2 (R1/R2), whereas Q14 concentrates on the creation of analytical techniques.

WHO: Herbal, chemical, and biological therapies. strong focus on method durability and transferability across other labs.

USP: both non-compendial and compendial (monograph) techniques. Validation and verification of USP addresses <1225> and <1226>.

3.  DETAILED COMPARISON OF VALIDATION CHARACTERISTICS

4.  Bio analytical Method Validation

5.  Analytical Procedure Lifecycle (APL)

6.  GLOBAL HARMONIZATION AND IMPLICATION

The original Q2 (R1) is modernized by ICH Q2(R2) (Analytical Validation), which incorporates a clear classification of procedures (e.g., identification, test, impurity).

ICH Q14 (Analytical Development): Describes methodical development using testing. performance-based testing, method control plan, and risk assessment.

Harmonization Trends:

ICH Q14 and Q2(R2) are being followed by the FDA, EMA, PMDA (Japan), and WHO. The general chapters (<1220>, <1225>) are being updated by USP to incorporate Life cycle concepts.

As a result, analytical packages are accepted globally and submissions are simplified.

SUMMARY